A detailed history of Gw&K Investment Management, LLC transactions in Pfizer Inc stock. As of the latest transaction made, Gw&K Investment Management, LLC holds 3,855 shares of PFE stock, worth $105,858. This represents 0.0% of its overall portfolio holdings.

Number of Shares
3,855
Previous 3,475 10.94%
Holding current value
$105,858
Previous $97,000 15.46%
% of portfolio
0.0%
Previous 0.0%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 07, 2024

BUY
$27.7 - $31.39 $10,526 - $11,928
380 Added 10.94%
3,855 $112,000
Q2 2024

Aug 12, 2024

BUY
$25.26 - $29.6 $23,239 - $27,232
920 Added 36.01%
3,475 $97,000
Q1 2024

May 08, 2024

SELL
$25.89 - $29.73 $6,809 - $7,818
-263 Reduced 9.33%
2,555 $71,000
Q4 2023

Feb 09, 2024

BUY
$26.13 - $33.94 $8,518 - $11,064
326 Added 13.08%
2,818 $81,000
Q3 2023

Nov 09, 2023

BUY
$32.09 - $37.51 $20,120 - $23,518
627 Added 33.62%
2,492 $83,000
Q2 2023

Aug 09, 2023

BUY
$36.12 - $41.79 $67,363 - $77,938
1,865 New
1,865 $68,000
Q2 2022

Aug 09, 2022

BUY
$46.53 - $55.17 $39,783 - $47,170
855 Added 60.25%
2,274 $119,000
Q1 2022

May 09, 2022

BUY
$45.75 - $56.69 $64,919 - $80,443
1,419 New
1,419 $73,000
Q4 2020

Feb 05, 2021

SELL
$33.47 - $42.56 $19,948 - $25,365
-596 Closed
0 $0
Q3 2020

Nov 10, 2020

BUY
$31.75 - $37.25 $18,923 - $22,201
596 New
596 $22,000
Q1 2018

May 08, 2018

SELL
$31.91 - $37.02 $229,943 - $266,766
-7,206 Closed
0 $0
Q4 2017

Jan 19, 2018

SELL
$33.26 - $35.29 $9.24 Million - $9.8 Million
-277,766 Reduced 97.47%
7,206 $261,000
Q3 2017

Oct 11, 2017

BUY
$31.0 - $34.15 $8.83 Million - $9.73 Million
284,972
284,972 $10.2 Million

Others Institutions Holding PFE

About PFIZER INC


  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $154B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track Gw&K Investment Management, LLC Portfolio

Follow Gw&K Investment Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Gw&K Investment Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Gw&K Investment Management, LLC with notifications on news.